PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1408892
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1408892
Cell Culture Media Storage Containers Market size was valued at USD 1,790 Million in 2022, expanding at a CAGR of 14% from 2023 to 2030.
Cell culture media storage containers play a crucial role in the field of cell culture and biotechnology. These containers are specifically designed to store and preserve cell culture media, which is a vital component in the growth and maintenance of cells in a laboratory setting. The proper storage of cell culture media is extremely important as it guarantees the integrity of the media components and the success of cell culture experiments. Cell culture work often requires adherence to specific regulations and standards, such as Good Cell Culture Practice (GCCP) or Good Manufacturing Practice (GMP). Containers must meet these standards to ensure the quality and reproducibility of experimental results.
The production of biopharmaceuticals involves complex cell culture processes, and as the demand for these drugs rises, there is a need for specialized storage containers to preserve the integrity of the cell culture media. The United States is the largest market for biopharmaceuticals, accounting for a significant portion of the global market and leading in biopharmaceutical R&D. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), biopharmaceutical firms spent about USD97 billion on R&D in the U.S. in 2017- more than any other industry. Cell-based therapies, such as gene therapies and immunotherapies, are also gaining prominence in the healthcare industry. Technological innovations in cell culture, such as 3D cell culture and advanced bioreactor systems, present opportunities for the Cell Culture Media Storage Containers Market. However, the market growth may be hindered by factors such as increasing awareness of sustainability and environmental impact, which can influence purchasing decisions.
Geographically, this market spans across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries involved in business activities. The growth of the market is expected to be dominated by North America, primarily due to its well-established infrastructure, advanced facilities, and a strong manufacturing industry. In particular, the United States possesses a highly developed infrastructure that supports the biopharmaceutical and biotechnology sectors. In 2018, the U.S. spent 16.9 percent of gross domestic product (GDP) on health care, nearly twice as much as the average OECD country. The second-highest ranking country, Switzerland, spent 12.2 percent. At the other end of the spectrum, New Zealand and Australia devote only 9.3 percent, approximately half as much as the U.S. does, according to U.S. Health Care from a Global Perspective. Despite these challenges, the region boasts a robust and highly advanced manufacturing industry, particularly in the field of biopharmaceuticals. With a significant number of biotech companies and pharmaceutical manufacturers, there is a consistent need for cutting-edge storage solutions, including containers for cell culture media.
To ensure the integrity of their final products, many biopharmaceutical manufacturers have transitioned from using media containing animal-derived components. They have also adopted media with plant-based hydrolysates to minimize the variability of raw materials, which can impact the quality and productivity of the products. However, the development of CD media presents its own challenges. CD media can be sensitive to changes in raw material sources and the mixing and blending processes involved in production. Additionally, storage conditions are crucial for maintaining the quality of CD media. To remain competitive, companies are investing in material innovation to enhance the quality and performance of storage containers. The use of innovative materials offers advantages such as improved gas permeability, reduced leachables and extractables, and increased durability. Companies with a global presence and efficient distribution networks have a stronger competitive position. The ability to supply Cell Culture Media Storage Containers to research institutions, biopharmaceutical companies, and other end-users worldwide is a key factor in gaining market share.
March 22, 2021 Thermo Fisher Scientific today launched the new Gibco Human Plasma-like Medium (HPLM), the first cell culture medium on the market that mimics the metabolic profile of human plasma that is designed to provide researchers with a realistic view of cell growth within the human body.
The scope of this report covers the market by its major segments, which include as follows: